Table 6.
Organ/cell | Administration | Effective concentration | References |
---|---|---|---|
Lung | H2 inhalation | 2% | 8, 13, 15, 20 |
HRS 8 ml/kg i.v. | > 0.6 mmol/L | 11 | |
HRS 10 ml/kg i.p. | > 0.6 mmol/L | 14 | |
HRW po. | 0.25-1.6 mmol/L | 16 | |
Liver | HRW po. | 0.6 mmol/L | 6 |
HRS 8 ml/kg i.p. | > 0.6 mmol/L | 21 | |
HRS 8 ml/kg i.v. | > 0.6 mmol/L | 22 | |
Kidney | H2 inhalation | 2% | 24, 25 |
HRS 5 ml/kg i.p. | > 0.6 mmol/L | 23 | |
Brain | H2 inhalation | 2% | 26 |
Pancreas | HRW 6 ml/kg po. | 0.62-0.82 mmol/L | 27 |
Heart | HRS 10 ml/kg i.p. | > 0.6 mmol/L | 7 |
Eye | HRS 10 ml/kg i.p. | > 0.6 mmol/L | 10 |
Endothelial cell | HRM incubation | 0.6 mmol/L | 30, 35, 36, 38 |
HRS 5 ml/kg i.p. | > 0.6 mmol/L | 36 | |
Epithelial cell | HRS 8 ml/kg gavage | 0.7 mmol/L | 29 |
HRS 8 ml/kg i.v. | > 0.6 mmol/L | 11 | |
HRM incubation | 0.6 mmol/L | 9 |